EUVIMEDEUVIMED entdecken
Crossref

Guiqi Huoxue capsule alleviates cervical spondylosis in rats: Insights from 16S rRNA sequencing, lipidomics, and network pharmacology

Hongguang Tang, Wenting Ni, Dejun Niu, Kun Wang, Mengmeng Shen, Fanqiang Meng, Deyu Cui, Zhen Zeng, Chenghong Sun, Jinyang Shen, Shirong Li, Yue Zhou

Journal of Ethnopharmacology · 2025

DOI: 10.1016/j.jep.2025.119752 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025. Verfasst von Hongguang Tang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Jiangsu Ocean University, Lianyungang, 222005, China. Electronic address: tanghg2022@163.com. Hauptthemen laut MEDLINE: Spondylosis, Drugs, Chinese Herbal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Cervical spondylosis (CS) is a common condition primarily caused by intervertebral disc degeneration (IVDD), adversely affecting quality of life. Traditional Chinese medicine believes that Qi deficiency and blood stasis are the main pathogenesis of CS. Guiqi Huoxue capsule (GQHX) has the effect of beneficial Qi tonifying kidneys and promoting blood circulation, which is mainly used in the clinical treatment of CS (Qi deficiency and blood stasis syndrome). However, the underlying mechanism of action has not been reported and clarified. AIM OF THE STUDY: The aim of this study was to investigate the efficacy and underlying mechanisms of GQHX in CS rats. MATERIALS AND METHODS: The CS rat model (Qi deficiency and blood stasis syndrome) was established by using IVDD and Ovariectomy (OVX) surgeries, along with qi deficiency and blood stasis modeling. The effects of GQHX on CS rats were evaluated by behavioral tests, blood indexes, H&E staining, and other means. Fatty acid profiles and gut microbiota were analyzed using lipidomics and 16S rRNA sequencing. The mechanism of action of GQHX was investigated by network pharmacology and western blotting. RESULTS: GQHX reduced the symptoms of CS rats as confirmed by behavioral indicators, serum markers, and other measures of efficacy. Meanwhile, 16S rRNA sequencing and lipidomics results showed that GQHX regulated the abundance of Blautia and Muribaculaceae, influencing the production of various fatty acids (e.g. isobutyric, isovaleric, and linoleic acids). More importantly, network pharmacology and Western blot results suggested that GQHX could alleviate the clinical symptoms of CS by regulating the abnormal expression of AGE-RAGE, MAPK, and HIF-1 signaling pathways. CONCLUSION: This study elucidated the role of GQHX in alleviating CS and highlighted the mechanisms involved, particularly the regulation of gut microbiota and lipid metabolism, as well as the AGE-RAGE, MAPK, and HIF-1 signaling pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SpondylosisDrugs, Chinese HerbalAnimalsFemaleRats, Sprague-DawleyRatsNetwork PharmacologyCapsulesRNA, Ribosomal, 16SLipidomicsDisease Models, AnimalGastrointestinal MicrobiomeQi

Stichwörter der Autor:innen

Cervical spondylosisFatty acid metabolismGuiqi Huoxue capsulesGut microbiotaPharmacological mechanisms

Substanzen

Drugs, Chinese HerbalCapsulesRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Pharmacy, Jiangsu Ocean University, Lianyungang, 222005, China. Electronic address: tanghg2022@163.com.
  • College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China. Electronic address: 1258022966@qq.com.
  • State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co. Ltd., Linyi, 276005, China. Electronic address: 18754299560@163.com.
  • College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China. Electronic address: 18086313217@163.com.
  • State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co. Ltd., Linyi, 276005, China. Electronic address: 13012763172@163.com.
  • State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co. Ltd., Linyi, 276005, China. Electronic address: beijing-0539@163.com.

Zitieren

APA

Tang, H., Ni, W., Niu, D., Wang, K., Shen, M., Meng, F., Cui, D., Zeng, Z., Sun, C., Shen, J., Li, S., & Zhou, Y. (2025). Guiqi Huoxue capsule alleviates cervical spondylosis in rats: Insights from 16S rRNA sequencing, lipidomics, and network pharmacology. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.119752

Vancouver

Tang H, Ni W, Niu D, Wang K, Shen M, Meng F, et al. Guiqi Huoxue capsule alleviates cervical spondylosis in rats: Insights from 16S rRNA sequencing, lipidomics, and network pharmacology. Journal of Ethnopharmacology. 2025. doi:10.1016/j.jep.2025.119752

BibTeX
@article{Tang2025,
  author = {Tang, Hongguang and Ni, Wenting and Niu, Dejun and Wang, Kun and Shen, Mengmeng and Meng, Fanqiang and Cui, Deyu and Zeng, Zhen and Sun, Chenghong and Shen, Jinyang and Li, Shirong and Zhou, Yue},
  title = {Guiqi Huoxue capsule alleviates cervical spondylosis in rats: Insights from 16S rRNA sequencing, lipidomics, and network pharmacology},
  journal = {Journal of Ethnopharmacology},
  year = {2025},
  doi = {10.1016/j.jep.2025.119752}
}
Kostenlos starten →